Novel Digital Anomalies, Hippocampal Atrophy, and Mutations Expand the Genotypic and Phenotypic Spectra of CNKSR2 in the Houge Type of X‐Linked Syndromic Intellectual Development Disorder (MRXSHG)
Authors: Ghasemi Mohammad‐Reza , Fateh Sahand Tehrani , Ben‐Mahmoud Afif , Gupta Vijay , Stühn Lara G. , Lesca Gaetan , Chatron Nicolas , Platzer Konrad , Edery Patrick , Sadeghi Hossein , Isidor Bertrand , Cogné Benjamin , Schulz Heidi L. , Krauspe‐Stübecke Ilona , Periyasamy Radhakrishnan , Nampoothiri Sheela , Mirfakhraie Reza , Alijanpour Sahar , Syrbe Steffen , Pfeifer Ulrich , Spranger Stephanie , Grundmann‐Hauser Kathrin , Haack Tobias B. , Papadopoulou Maria T. , da Silva Gonçalves Tayrine , Panagiotakaki Eleni , Arzimanoglou Alexis , Tonekaboni Seyed Hassan , Rossi Massimiliano , Korenke G. Christoph , Lacassie Yves , Jang Mi‐Hyeon , Layman Lawrence C. , Miryounesi Mohammad , Kim Hyung‐Goo 
Published: December 2024

The Houge type of X‐linked syndromic intellectual developmental disorder (MRXSHG) encompasses a spectrum of neurodevelopmental disorders characterized by intellectual disability (ID), language/speech delay, attention issues, and epilepsy. These conditions arise from hemizygous or heterozygous deletions, along with point mutations, affecting CNKSR2, a gene located at Xp22.12. CNKSR2, also known as CNK2 or MAGUIN, functions as a synaptic scaffolding molecule within the neuronal postsynaptic density (PSD) of the central nervous system. It acts as a link connecting postsynaptic structural proteins, such as PSD95 and S‐SCAM, by employing multiple functional domains crucial for synaptic signaling and protein–protein interactions. Predominantly expressed in dendrites, CNKSR2 is vital for dendritic spine morphogenesis in hippocampal neurons. Its loss‐of‐function variants result in reduced PSD size and impaired hippocampal development, affecting processes including neuronal proliferation, migration, and synaptogenesis. We present 15 patients including three from the MENA (Middle East and North Africa), a region with no documented mutations in CNKSR2. Each individual displays unique clinical presentations that encompass developmental delay, ID, language/speech delay, epilepsy, and autism. Genetic analyses revealed 14 distinct variants in CNKSR2, comprising five nonsense, three frameshift, two splice, and four missense variants, of which 13 are novel. The ACMG guidelines unanimously interpreted these 14 variants in 15 individuals as pathogenic, highlighting the detrimental impact of these CNKSR2 genetic alterations and confirming the molecular diagnosis of MRXSHG. Importantly, variants Ser767Phe and Ala827Pro may lead to proteasomal degradation or reduced PSD size, contributing to the neurodevelopmental phenotype. Furthermore, these two amino acids, along with another two affected by four missense variants, exhibit complete conservation in nine vertebrate species, illuminating their crucial role in the gene's functionality. Our study revealed unique new digital and brain phenotype, including pointed fingertips (fetal pads of fingertips), syndactyly, tapering fingers, and hippocampal atrophy. These novel clinical features in MRXSHG, combined with 13 novel variants, expand the phenotypic and genotypic spectra of MRXSHG associated with CNKSR2 mutations.